Please use this identifier to cite or link to this item: http://hdl.handle.net/ir.unikl.edu.my/34901
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMulenga, Glovanna-
dc.contributor.authorAlahmed, Teejan Ameer Abed-
dc.contributor.authorSami, Farheen-
dc.contributor.authorMajeed, Shahnaz-
dc.contributor.authorAli, Md Sajid-
dc.contributor.authorLe, Janice Lo Jia-
dc.contributor.authorRhu, Carol Lee Qhai-
dc.contributor.authorNair, Rajesh Sreedharan-
dc.contributor.authorHasan, Nadeem-
dc.contributor.authorAnsari, Mohammed Tahir-
dc.contributor.author(UniKL RCMP)-
dc.date.accessioned2026-06-23T07:19:52Z-
dc.date.available2026-06-23T07:19:52Z-
dc.date.issued2024-06-
dc.identifier.citationMulenga G, Alahmed TAA, Sami F, Majeed S, Ali MS, Lo Jia Le J, et al. QbD Assisted Systematic Review for Optimizing the Selection of PVP as a Ternary Substance in Enhancing the Complexation Efficiency of Cyclodextrins: a Pilot Study. AAPS PharmSciTech [Internet]. 2024 Jun 11;25(5):134. Available from: https://doi.org/10.1208/s12249-024-02845-3en_US
dc.identifier.issn15309932-
dc.identifier.urihttps://link.springer.com/article/10.1208/s12249-024-02845-3-
dc.identifier.urihttps://ir.unikl.edu.my/jspui/handle/ir.unikl.edu.my/34901-
dc.description.abstractInclusion complexes require higher concentration of Beta cyclodextrins (βCD) resulting in increased formulation bulk, toxicity, and production costs. This systematic review offers a comprehensive analysis using Quality by design (QbD) as a tool to predict potential applications of Polyvinylpyrrolidone (PVP) as a ternary substance to address issues of inclusion complexes. We reviewed 623 documents from 2013 to 2023 and Eighteen (18) research papers were selected for statistical and meta-analysis using the QbD concept to identify the most critical factors for selecting drugs and effect of PVP on inclusion complexes. The QbD analysis revealed that Molecular weight (MW), Partition coefficient (Log P), and the auxiliary substance ratio directly affected complexation efficiency (CE), thermodynamic stability in terms of Gibbs free energy (ΔG), and percent drug release. However, Stability constant (Ks) remained unaffected by any of these parameters. The results showed that low MW (250), median Log P (6), and a βCD: PVP ratio of 2:3 would result in higher CE, lower G, and improved drug release. PVP improves drug solubility, enhances delivery and therapeutic outcomes, and counteracts increased drug ionization due to decreased pH. In certain cases, its bulky nature and hydrogen bonding with CD molecules can form non-inclusion complexes. The findings of the study shows that there is potential molecular interaction between PVP and β-cyclodextrins, which possibly enhances the stability of inclusion complexes for drug with low MW and log P values less than 9. The systematic review shows a comprehensive methodology based on QbD offers a replicable template for future investigations into drug formulation research.en_US
dc.language.isoenen_US
dc.publisherSpringer Science and Business Media Deutschland GmbHen_US
dc.subjectbeta cyclodextrins (βCD)en_US
dc.subjectbox behnken designen_US
dc.subjectlog Pen_US
dc.subjectpolyvinylpyrrolidone (PVP)en_US
dc.subjectquality by design (QbD)en_US
dc.subjectternary substanceen_US
dc.titleQbD Assisted Systematic Review for Optimizing the Selection of PVP as a Ternary Substance in Enhancing the Complexation Efficiency of Cyclodextrins: a Pilot Studyen_US
dc.typeArticleen_US
Appears in Collections:Journal Articles



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.